Abstract
Aging is characterized by a progressive decline in cellular function, regenerative capacity, and metabolic efficiency, leading to tissue dysfunction and age-related diseases. Pharmacological interventions targeting cellular resilience pathways represent a promising approach for delaying or reversing age-associated decline. The small molecule RT175, a non-immunosuppressive immunophilin ligand, has shown potential in enhancing mitochondrial function to promote healthy aging. Using a melanoblast cell line, our results showed that RT175 induced cell growth inhibition, enhanced pigmentation, altered mitochondrial gene expression, increased mitochondrial DNA content, and inhibit GSK3β. RT175 also promoted in vivo tissue regeneration, suggesting that RT175 exerts pro-regenerative effects by regulating gene expression program governing mitochondrial metabolism, melanogenesis, and cellular plasticity. These findings highlight RT175 as a potential therapeutic for aging-related decline.
Recommended Citation
Polycarp, Nunaya; Ryan, Chase; Ahmed, Noha; and Benavides, Gloria
(2026)
"Targeting FKBPs to Regulate GSK3β to Impact Aging,"
Journal of the Alabama Academy of Sciences: Vol. 97:
No.
1, Article 17.
Available at:
https://jagworks.southalabama.edu/jaas/vol97/iss1/17
